Barbit 30mg Tablet

Barbit 30mg Tablet, also known as phenobarbitone or phenobarbital, is used to treat various types of seizures except for absence seizures. It can also be used to manage epilepsy, insomnia, and drug withdrawal symptoms.

Barbit 30mg Tablet works by affecting GABA receptors in the brain, leading to the production of GABA, an amino acid that reduces neuron excitability. However, there is a potential for drug dependency, and sudden cessation may lead to withdrawal symptoms, including status epilepticus in epileptic patients.

The drug is not recommended for patients with porphyria, hypersensitivity or allergy to barbiturates, respiratory insufficiency, hyperkinesia, liver cell deterioration, and other liver problems. Caution should be exercised when using it with certain drugs like aceprometazine and adipilon.

Common side effects of Barbit 30mg Tablet include drowsiness, excitation, irritability, loss of balance or coordination, headache, loss of appetite, nausea, vomiting, and constipation. More severe side effects such as insomnia, hypoventilation, apnea, hypotension, and syncope may also occur, requiring medical attention. Therefore, it is essential to consult a doctor to determine the appropriate dosage and avoid unwanted and severe side effects.

In case of overdose, symptoms may include unsteady gait, slurred speech, confusion, jaundice, hypothermia, hypotension, respiratory depression, and coma. If hypotension occurs, intravenous fluids and positioning the patient in the Trendelenburg position may be necessary. In severe cases, an intravenous vasopressor (e.g., dopamine, epinephrine) might be required.

Activated charcoal can be used to reduce the half-life of phenobarbital through nonrenal elimination. Adequate hydration and renal function should be ensured. Urinary alkalinization with intravenous sodium bicarbonate can also enhance elimination. Hemodialysis or hemoperfusion may be considered for patients in stage IV coma due to high serum barbiturate levels.